Synapse

← Bruce D. Walker

Papers by Bruce D. Walker

Page 8 · newest first

  1. Limited Sequence Evolution within Persistently Targeted CD8 Epitopes in Chronic Human Immunodeficiency Virus Type 1 InfectionJournal of Virology · 2005
  2. Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon ProteinThe Journal of Immunology · 2005
  3. HIV-1 Viral Escape in Infancy Followed by Emergence of a Variant-Specific CTL ResponseThe Journal of Immunology · 2005
  4. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infectionBlood · 2005
  5. The Majority of Currently Circulating Human Immunodeficiency Virus Type 1 Clade B Viruses Fail To Prime Cytotoxic T-Lymphocyte Responses against an Otherwise Immunodominant HLA-A2-Restricted Epitope: Implications for Vaccine DesignJournal of Virology · 2005
  6. The magnitude and breadth of hepatitis C virus–specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1Blood · 2005
  7. CD8 Epitope Escape and Reversion in Acute HCV InfectionThe Journal of Experimental Medicine · 2004
  8. Major histocompatibility complex class I–intercellular adhesion molecule‐1 association on the surface of target cells: implications for antigen presentation to cytotoxic T lymphocytesImmunology · 2004
  9. Limited Durability of Viral Control following Treated Acute HIV InfectionPLoS Medicine · 2004
  10. Loss of HIV-1–specific CD8+ T Cell Proliferation after Acute HIV-1 Infection and Restoration by Vaccine-induced HIV-1–specific CD4+ T CellsThe Journal of Experimental Medicine · 2004
  11. A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognitionProceedings of the National Academy of Sciences · 2004
  12. IL-8 responsiveness defines a subset of CD8 T cells poised to killBlood · 2004
  13. Heat Shock Protein-Mediated Cross-Presentation of Exogenous HIV Antigen on HLA Class I and Class IIThe Journal of Immunology · 2004
  14. Immune Escape Precedes Breakthrough Human Immunodeficiency Virus Type 1 Viremia and Broadening of the Cytotoxic T-Lymphocyte Response in an HLA-B27-Positive Long-Term-Nonprogressing ChildJournal of Virology · 2004
  15. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversityAIDS · 2004
  16. Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 InfectionJournal of Virology · 2004
  17. CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjectsJournal of Translational Medicine · 2004
  18. Differences in the Expressed HLA Class I Alleles Effect the Differential Clustering of HIV Type 1-Specific T Cell Responses in Infected Chinese and CaucasiansAIDS Research and Human Retroviruses · 2004
  19. Migration ofAntigen-Specific T Cells Away from CXCR4-Binding Human ImmunodeficiencyVirus Type 1gp120Journal of Virology · 2004
  20. Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance ofgagandnefand the Presence of Broadly Recognized PeptidesJournal of Virology · 2004
  21. HIV-1–specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-γ and tumor necrosis factor–αBlood · 2004
  22. Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 InfectionThe Journal of Experimental Medicine · 2004
  23. Impact of intrapeptide epitope location on CD8 T cell recognitionAIDS · 2004
  24. The immune response to AIDS virus infection: good, bad, or both?Journal of Clinical Investigation · 2004
  25. Fine Specificity and Cross-Clade Reactivity of HIV Type 1 Gag-Specific CD4 ⁺ T CellsAIDS Research and Human Retroviruses · 2004
  26. Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?AIDS · 2004
  27. Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple EthnicitiesJournal of Virology · 2004
  28. Pervasive Influence of Hepatitis C Virus on the Phenotype of Antiviral CD8+ T CellsThe Journal of Immunology · 2004
  29. Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 InfectionJournal of Virology · 2003
  30. Progress in Defining CD4 Helper Cell Responses in Chronic Viral InfectionsThe Journal of Experimental Medicine · 2003
  31. Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant VirusClinical Infectious Diseases · 2003
  32. Reconstitution of Virus-Specific CD4 Proliferative Responses in Pediatric HIV-1 InfectionThe Journal of Immunology · 2003
  33. Drug Induced QT Prolongation: Lessons from Congenital and Acquired Long QT SyndromesCardiovascular & Haematological Disorders - Drug Targets · 2003
  34. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infectionAIDS · 2003
  35. Impacts of Avidity and Specificity on the Antiviral Efficiency of HIV-1-Specific CTLThe Journal of Immunology · 2003
  36. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersJournal of Clinical Investigation · 2003
  37. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersJournal of Clinical Investigation · 2003
  38. Comprehensive Screening Reveals Strong and Broadly Directed Human Immunodeficiency Virus Type 1-Specific CD8 Responses in Perinatally Infected ChildrenJournal of Virology · 2003
  39. Enhanced Detection of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses to Highly Variable Regions by Using Peptides Based on Autologous Virus SequencesJournal of Virology · 2003
  40. Determinants of HIV-1 Mutational Escape From Cytotoxic T LymphocytesThe Journal of Experimental Medicine · 2003
  41. Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunizationAIDS · 2003
  42. Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infectionAIDS · 2003
  43. Viremia Control Despite Escape from a Rapid and Potent Autologous Neutralizing Antibody Response After Therapy Cessation in an HIV-1-Infected IndividualThe Journal of Immunology · 2003
  44. Immunogenicity of a Recombinant Human Immunodeficiency Virus (HIV)–Canarypox Vaccine in HIV‐Seronegative Ugandan Volunteers: Results of the HIV Network for Prevention Trials 007 Vaccine StudyThe Journal of Infectious Diseases · 2003
  45. Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral LoadJournal of Virology · 2003
  46. HIV-1 Antiviral Activity of Recombinant Natural Killer Cell Enhancing Factors, NKEF-A and NKEF-B, Members of the Peroxiredoxin FamilyJournal of Biological Chemistry · 2003
  47. Broad Specificity of Virus-Specific CD4+T-Helper-Cell Responses in Resolved Hepatitis C Virus InfectionJournal of Virology · 2002
  48. Purification of a Modified Form of Bovine Antithrombin III as an HIV-1 CD8+ T-cell Antiviral FactorJournal of Biological Chemistry · 2002
  49. HIV-1 Superinfection — A Word of CautionNew England Journal of Medicine · 2002
  50. Consistent Patterns in the Development and Immunodominance of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8⁺T-Cell Responses following Acute HIV-1 InfectionJournal of Virology · 2002